Last Updated On 4/5/2023 1:21:14 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| Company: START |
| Recipient: You |
| Company: HM Hospitales Group |
| Recipient: You |
|
| Leadership |
| Company: START |
| Recipient: You |
| Company: PharmaMar |
| Recipient: You |
| Company: EORTC |
| Recipient: You |
| Company: Sanofi |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Merus NV |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: START |
| Recipient: You |
| Company: Oncoart Associated |
| Recipient: You |
|
| Honoraria |
| Company: HM Hospitales Group |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Nanobiotix |
| Recipient: You |
| Company: Janssen-Cilag |
| Recipient: You |
| Company: Roche/Genentech |
| Recipient: You |
| Company: TargImmune Therapeutics |
| Recipient: You |
| Company: Servier |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Amunix |
| Recipient: You |
| Company: Adcendo |
| Recipient: You |
| Company: Anaveon |
| Recipient: You |
| Company: AstraZeneca/MedImmune |
| Recipient: You |
| Company: Chugai Pharma |
| Recipient: You |
| Company: MonTa |
| Recipient: You |
| Company: MSD Oncology |
| Recipient: You |
| Company: Nouscom |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: OncoDNA |
| Recipient: You |
| Company: T-Knife |
| Recipient: You |
| Company: Elevation Oncology |
| Recipient: You |
| Company: PharmaMar |
| Recipient: You |
| Company: Ellipses Pharma |
| Recipient: You |
| Company: Syneos Health |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Diaccurate |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: START |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: President and Founder of Foundation INTHEOS (Investigational Therapeutics in Oncological Sciences) |
| Recipient: You |
| Company: Non for profit Foundation PharmaMar |
| Recipient: You |
| Company: Non-for-profit CRIS Cancer Foundation |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|